We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

108 hedge funds and large institutions have $452M invested in MaxCyte in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

41% more capital invested

Capital invested by funds: $321M → $452M (+$131M)

34% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 29

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

6% more funds holding

Funds holding: 102 → 108 (+6)

1.44% more ownership

Funds ownership: 66.98% → 68.42% (+1.4%)

Holders
108
Holders Change
+6
Holders Change %
+5.88%
% of All Funds
1.86%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
18
Increased
39
Reduced
29
Closed
11
Calls
$99K
Puts
–
Net Calls
+$99K
Net Calls Change
+$14K

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$18M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.08M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.43M
4
BlackRock
BlackRock
New York
+$4.38M
5
Swedbank
Swedbank
Sweden
+$3.9M

Top Sellers

1
CC
Casdin Capital
New York
-$18M
2
Millennium Management
Millennium Management
New York
-$5.19M
3
Goldman Sachs
Goldman Sachs
New York
-$4.65M
4
RI
RTW Investments
New York
-$3.65M
5
Citigroup
Citigroup
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
51
CAPTRUST Financial Advisors
North Carolina
$652K +$559K +100,203 +196,476%
HFA
52
Harbert Fund Advisors
Alabama
$639K – – –
GIM
53
Granahan Investment Management
Massachusetts
$638K +$548K +98,201 New
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$621K -$21.3K -3,822 -4%
FAM
55
Fred Alger Management
New York
$596K – – –
SEI Investments
56
SEI Investments
Pennsylvania
$570K -$8.72K -1,563 -2%
TA
57
Tamarack Advisers
California
$534K +$458K +82,099 New
Fidelity Investments
58
Fidelity Investments
Massachusetts
$420K +$11.8K +2,116 +3%
UBS AM
59
UBS AM
Illinois
$409K – – –
MA
60
Mudita Advisors
United Kingdom
$398K +$342K +61,234 New
SO
61
STRS Ohio
Ohio
$393K +$199K +35,700 +144%
MIM
62
MetLife Investment Management
New Jersey
$365K – – –
Jane Street
63
Jane Street
New York
$352K +$155K +27,759 +105%
AG
64
Algert Global
California
$286K +$245K +43,934 New
CS
65
Credit Suisse
Switzerland
$284K +$2.81K +503 +1%
Mirae Asset Global Investments
66
Mirae Asset Global Investments
South Korea
$273K +$61.3K +10,999 +36%
AIG
67
American International Group
New York
$269K +$3.25K +583 +1%
DekaBank Deutsche Girozentrale
68
DekaBank Deutsche Girozentrale
Germany
$241K – – –
Deutsche Bank
69
Deutsche Bank
Germany
$230K -$32.4K -5,812 -14%
AR
70
Advisory Research
Illinois
$230K +$198K +35,410 New
Point72 Asset Management
71
Point72 Asset Management
Connecticut
$227K +$195K +34,900 New
VA
72
Valmark Advisers
Ohio
$225K +$193K +34,559 New
VOYA Investment Management
73
VOYA Investment Management
Georgia
$224K – – –
Invesco
74
Invesco
Georgia
$223K -$45.5K -8,157 -19%
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$220K -$4.26K -763 -2%
1 2
3
4 5

MXCT Hedge Fund Activity: Q3 2022 in Review

108 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2022, worth a combined $452M — up 41% from $321M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MXCT positions and 11 closed out — a net gain of 7 holders — while 39 added to existing stakes and 29 trimmed.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $18M. The largest seller was Casdin Capital, cutting an estimated $18M.

  • 108 institutional investors held MaxCyte (MXCT) as of Q3 2022, up from 102 in Q2 2022.
  • Funds reported $452M of MaxCyte stock for Q3 2022, up 41% quarter-over-quarter.
  • 18 funds opened new MaxCyte positions in Q3 2022 and 11 closed out, a net change of +7 holders.
  • The largest MaxCyte buyer in Q3 2022 was Blue Water Life Science Advisors, an estimated $18M added.
  • The largest MaxCyte seller in Q3 2022 was Casdin Capital, an estimated $18M sold.

Based on aggregated 13F filings for Q3 2022.